Earnings Call · Q4 FY2022·2023-03-09

Q4 22EPS +93.33%·Rev n/aQ3 22EPS -75.00%·Rev n/aQ2 22EPS -100.00%*·Rev n/aQ1 22EPS -50.00%·Rev n/a⚠ consensus missing

Cytosorbents Corp CTSO

Jodi Hoover — Investor Relations

Phillip Chan — Chief Executive Officer

Irina Kulinets — Vice President of Regulatory Affairs

Kathleen Bloch — Chief Financial Officer

Efthymios Deliargyris — Vice President of Medical Affairs

Christian Steiner — Chief Commercial Officer

Vincent Capponi — President and Chief Operating Officer

0.0%1d on move date+1.4% vs SPY3d−4.2%5d−9.2%

Research tier

Behavioral profile computed for 7 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CTSO calls or request research access.

More CTSO calls Browse calls Request research access